Shares Issued
As at 22 October 2024, the number of shares in issue was 95,952,912. The company does not hold any ordinary shares in treasury.
Significant Shareholders
At 2 October 2024, the Company has been notified of the following interests in 3% or more of the issued ordinary share capital of the Company:
| Shareholder | No. of ordinary shares | % of issued share capital |
|---|---|---|
| Unicorn Asset Management Limited | 6,397,290 | 6.71% |
| Amati AIM VCT plc | 4,716,463 | 4.94% |
| Rathbone Investment Management Ltd | 4,513,062 | 4.73% |
| Invest Northern Ireland | 3,197,865 | 3.35% |
Director Shareholdings
| Director | No. of ordinary shares | % of issued share capital |
|---|---|---|
| Colin James Walsh 2 | 2,887,801 3 | 3.01% |
| Dr Richard John Buick | 1,000,000 | 1.05% |
| Dr Simon Gordon Douglas | 999,587 1 | 1.04% |
| Dr Adrian Kinkaid | 750,000 | 0.79% |
| Matthew Baker | 237,575 | 0.25% |
| Stephen Smyth | - | 0.00% |
1 Excludes Ordinary Shares held by relatives of Simon Douglas
2Held by Walsh Strategic Management Limited, a company controlled by Colin Walsh
3Includes 600,000 Ordinary Shares held by Walsh Strategic Management Limited, a company controlled by Colin Walsh and 1,400,000 Ordinary Shares held by Hamniv (GP) Limited, a subsidiary of Crescent Capital NI Limited ("Crescent Capital"). Colin Walsh is the Chief Executive and founder of Crescent Capital,
Shares not in public hands
Insofar as it is aware, as at 2 October 2024, 6.10% of the Company's securities is not in public hands.
Statement of the Rights of Shareholders
The rights of shareholders are governed by UK law.
Restrictions in transfer of AIM securities
There are no restrictions on the transfer of the Company's ordinary shares.
UK City Code on Takeovers and Mergers
The Company is subject to the provisions of the City Code on Takeover and Mergers.
Other exchanges and trading platforms
Fusion Antibodies has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.
Shareholder Circulars
Page last updated: 22 October 2024
